Global Cardio-Oncology Summit 2025: Advancing Cancer and Heart Health

58 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
The Global Cardio-Oncology Summit (GCOS) 2025 brought together cardiology and oncology experts to discuss the latest advancements in managing heart complications in cancer patients. Maria Sol Andres shares key insights from this international conference.
Cancer and Heart Health Research:
- Exploring the link between cancer cells and unloaded hearts.
- The role of ferroptosis in cardiotoxicity.
- Importance of avoiding IV iron during anthracycline treatment.
Developing New Cancer Drugs:
- Dr. Ruth Plummer discusses the path to clinic and cardiotoxicity monitoring.
- Emphasizing the need for tailored doses, continuous cardiac monitoring, and grading toxicities.
- The future of cancer treatment with antibody-drug conjugates, immunotherapy, and genomic profiling.
Primary Care in Cardio-Oncology:
- Dr. Siva Tharshini Ramalingam highlights the role of primary care physicians in early detection of cardiovascular side effects.
- The importance of education and diagnostic challenges in cancer therapy.
Cardio-Oncology in Africa:
- Insights from Souhila Ouabdesselam, Dr. Kieran Mwazo, Nana Poku, and Trishun Singh on the challenges and opportunities in Africa.
- Strategies for improvement: preventive medicine, cardiovascular risk modification, pharmacist empowerment, and political advocacy.
Venous Thromboembolism Management:
- Dr. Sebastian Szmit presents the API-CAT trial, showing the effectiveness of reduced-dose Apixaban for extended anticoagulation.
Stay tuned for more updates from the world of cardio-oncology research and innovation!
Categoria
Oncology
Commenta per primo questo video.

Prossimo